Agenus (AGEN) executive Klaskin sold 11,120 shares for $72.3K at $6.50
Insider transactions reported
Christine M Klaskin (executive at Agenus Inc., AGEN) reported that they sold 11,120 shares for $72.3K at $6.50, and acquired 16,563 shares at $3.36 on Sep 10, 2021. After these transactions the filing shows 93,056 shares held directly.
- Reporting person
- Klaskin Christine M
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 10, 2021 | Exercise or conversion of a derivative (M) | Common Stock1, 2 | +16,563 | $3.36 | $55.7K | 104,176 direct |
| Sep 10, 2021 | Open-market sale (S) | Common Stock3 | -11,120 | $6.50 | $72.3K | 93,056 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 10, 2021 | Exercise or conversion of a derivative (M) | Stock Option, right to buyOn 16,563 Common Stock | -16,563 | - | - | 0 direct |
Holdings before and after
- Common Stock: 87,613 to 93,056 direct
- Stock Option, right to buy: 16,563 to 0 direct
Footnotes from the filing
- 1. The options subject to the transaction reported on this Form 4 would have expired on September 14, 2021.
- 2. The number of shares beneficially owned by the reporting person does not reflect 998 shares that were incorrectly reported on prior Form 4s.
- 3. Represents sales of shares, as a consequence of the exercise of options, to cover Federal, state and local tax withholding requirements and the exercise price payment related to the option exercise. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.47 to $6.52. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Klaskin report in this AGEN Form 4?
Christine M Klaskin (executive at Agenus Inc., AGEN) reported that they sold 11,120 shares for $72.3K at $6.50, and acquired 16,563 shares at $3.36 on Sep 10, 2021. After these transactions the filing shows 93,056 shares held directly.
How many AGEN shares does Klaskin hold after this filing?
The filing shows 93,056 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this AGEN insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for AGEN
Earlier insider filings at AGEN
- Sep 14, 2021SEC Form 4: Armen Garo H sold $533,696 worth of Common Stock (82,107 units at $6.50) and exercised 119,178 units of Common Stock at a strike of $3.36, increasing direct ownership by 5% to 770,773 units to cover taxes
- Jul 2, 2021SEC Form 4: ARMEN GARO H was granted 2,679 units of Common Stock, increasing direct ownership by 0.37% to 733,702 units
- Jul 2, 2021SEC Form 4: Buell Jennifer was granted 10,597 units of Common Stock, increasing direct ownership by 9% to 127,091 units
- Jul 2, 2021SEC Form 4: Hirsch Susan B was granted 4,908 units of Common Stock, increasing direct ownership by 56% to 13,637 units
- Jul 2, 2021SEC Form 4 filed by Corvese Brian
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2000
Follow AGEN and get a push notification the moment its next story breaks.